Usefulness of 18F-sodium fluoride PET/MR imaging for the assessment of cardiac amyloidosis.

Conclusion: These results showed the potential of NaF-PET/MR to diagnose cardiac amyloidosis and to differentiate ATTR and AL forms, confirming our preliminary published results (Trivieri et al. J Am Coll Cardiol 2016). Research Support: This work was supported by National Institutes of Health (NIH) grants NIH/NHLBI R01HL071021 (to Dr. Fayad) and NIH 5T32HL007824-18 (to Dr. Trivieri), and by British Heart Foundation grants SS/CH/09/002/26360, FS/13/77/30488, SS/CH/09/002/2636, FS/14/78/31020, CH/09/002 (to Dr. Dweck).

Source: Journal of Nuclear Medicine - May 24, 2017 Category: Nuclear Medicine Authors: Abgral, R., Trivieri, M., Dweck, M., Robson, P., Karakatsanis, N., Lala, A., Contreras, J., Gopalan, R., Fuster, V., Narula, J., Fayad, Z. Tags: The ' New Cardiomyopathies: Sarcoid, Amyloid, and Chemotherapy Source Type: research